MCI

You have access
Visual Versus Fully Automated Analyses of ¹⁸F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
Timo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, Alexander Drzezga, Stefan Förster, Hans Förstl, Oliver Goldhardt, Marion Ortner, Christian Sorg and Alexander Kurz

Journal of Nuclear Medicine February 1, 2016, 57 (2) 204-207; DOI: https://doi.org/10.2967/jnumed.115.163717
You have access
Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
Zhen Fan, Denise Harold, Giuseppe Pasqualetti, Julie Williams, David J. Brooks and Paul Edison

Journal of Nuclear Medicine May 1, 2015, 56 (5) 707-713; DOI: https://doi.org/10.2967/jnumed.114.149443
You have access
Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas and William H. Thies

Journal of Nuclear Medicine March 1, 2013, 54 (3) 476-490; DOI: https://doi.org/10.2967/jnumed.113.120618

Main menu